After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

MaxsMaking Inc. (the 'Company' or 'MaxsMaking'), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, today announced the pricing of its initial public ...